Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEUL
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
|
+$302M |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$273M |
| 3 |
Petrobras
PBR
|
+$272M |
| 4 |
BHP
BHP
|
+$266M |
| 5 |
Freeport-McMoran
FCX
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$460M |
| 2 |
FIEU
FI Enhanced Europe 50 ETN
FIEU
|
+$267M |
| 3 |
FLEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series B
FLEU
|
+$239M |
| 4 |
HDFC Bank
HDB
|
+$227M |
| 5 |
Comcast
CMCSA
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.36% |
| 2 | Technology | 15.02% |
| 3 | Healthcare | 11.86% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Consumer Staples | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Lantheus
LNTH
$6.49B
| $1.46M | ﹤0.01% |
100,058
-19,735
| -16% | -$304K |
|
|
IFX
502
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
| $1.45M | ﹤0.01% |
57,014
-3,110
| -5% | -$79.3K |
|
|
503
Petrobras Class A
PBR.A
$111B
| $1.45M | ﹤0.01% |
164,202
| – | – |
|
504
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $1.45M | ﹤0.01% |
27,884
-3,670
| -12% | -$190K |
|
|
IMGN
505
DELISTED
Immunogen Inc
IMGN
| $1.33M | ﹤0.01% |
136,808
-117
| -0.1% | -$1.23K |
|
506
iShares Global Financials ETF
IXG
$678M
| $1.28M | ﹤0.01% |
19,912
+422
| +2% | +$28.8K |
|
507
Banc of California
BANC
$3.03B
| $1.27M | ﹤0.01% |
65,221
-29,730
| -31% | -$569K |
|
508
Vanguard Total World Stock ETF
VT
$77.1B
| $1.22M | ﹤0.01% |
16,612
+4,020
| +32% | +$300K |
|
509
Northern Oil and Gas
NOG
$2.3B
| $1.22M | ﹤0.01% |
+38,650
| New | +$870K |
|
510
Oil States International
OIS
$488M
| $1.19M | ﹤0.01% |
+37,100
| New | +$1.25M |
|
511
McDonald's
MCD
$192B
| $1.19M | ﹤0.01% |
7,577
-230
| -3% | -$37.3K |
|
|
MCHB
512
Mechanics Bancorp
MCHB
$3.72B
| $1.18M | ﹤0.01% |
43,944
-11,179
| -20% | -$308K |
|
513
Toronto Dominion Bank
TD
$198B
| $1.18M | ﹤0.01% |
20,434
+2,959
| +17% | +$169K |
|
|
QTS
514
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.17M | ﹤0.01% |
29,536
| – | – |
|
515
Collegium Pharmaceutical
COLL
$1.15B
| $1.16M | ﹤0.01% |
48,796
-11,746
| -19% | -$289K |
|
|
DNR
516
DELISTED
Denbury Resources, Inc.
DNR
| $1.16M | ﹤0.01% |
+240,200
| New | +$901K |
|
517
Accenture
ACN
$102B
| $1.12M | ﹤0.01% |
6,873
+3,280
| +91% | +$510K |
|
518
W&T Offshore
WTI
$534M
| $1.12M | ﹤0.01% |
+156,800
| New | +$1.01M |
|
519
UnitedHealth
UNH
$376B
| $1.12M | ﹤0.01% |
4,566
-35
| -0.8% | -$8.4K |
|
|
INN
520
Summit Hotel Properties
INN
$746M
| $1.11M | ﹤0.01% |
77,700
-21,092
| -21% | -$306K |
|
521
Trane Technologies
TT
$101B
| $1.09M | ﹤0.01% |
12,121
+481
| +4% | +$42.2K |
|
522
Lockheed Martin
LMT
$134B
| $1.08M | ﹤0.01% |
3,658
-375
| -9% | -$121K |
|
|
DVAX
523
DELISTED
Dynavax Technologies
DVAX
| $1.07M | ﹤0.01% |
70,270
-18,253
| -21% | -$316K |
|
|
PGNX
524
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.06M | ﹤0.01% |
131,861
-171,831
| -57% | -$1.31M |
|
525
Wynn Resorts
WYNN
$10.3B
| $1.05M | ﹤0.01% |
6,250
-249
| -4% | -$46K |
|
Similar funds
Ken Fisher's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Fisher held 924 positions worth $77B, up 2.1% from $75.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q2 2018 filing shows 95 new, 298 increased, 389 reduced and 62 closed positions. Its largest new stake was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M. The largest sale was Amazon, an estimated $460M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2018 buy was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M.
- Ken Fisher added most to Barclays ETN+ FI Enhanced Europe 50 ETN Series C in Q2 2018, an estimated $273M increase.
- Ken Fisher's biggest Q2 2018 reduction was Amazon, cutting an estimated $460M.
- Ken Fisher fully exited Dr. Reddy's Laboratories in Q2 2018, selling an estimated $165M.
- Ken Fisher's ten largest holdings make up 26% of its $77B portfolio in Q2 2018.
- Ken Fisher opened 95 new positions and closed 62 in Q2 2018.
- Ken Fisher's portfolio value rose 2.1% quarter-over-quarter to $77B.
Based on Fisher Asset Management's 13F filing for Q2 2018, filed 9 Jul 2018.